Results obtained from seven studies which evaluated the relationship between SIRT3 expression and pathological differentiation in cancer patients, yielding a pooled OR of 0.46 (95% CI = 0.29–0.74, P = 0.001), indicating there is significant correlation between SIRT3 expression and pathological differentiation. This evidence concerns the gene SIRT3 and cancer.